Literature DB >> 17015911

Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?

Edgar J Rolleman, Marion de Jong, Roelf Valkema, Dik Kwekkeboom, Boen Kam, Eric P Krenning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17015911

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  4 in total

Review 1.  Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Authors:  Edgar J Rolleman; Marleen Melis; Roelf Valkema; Otto C Boerman; Eric P Krenning; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-14       Impact factor: 9.236

2.  Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues.

Authors:  M A Muros; M Varsavsky; P Iglesias Rozas; J Valdivia; J R Delgado; F Forrer; L Bodei; G Paganelli
Journal:  Clin Transl Oncol       Date:  2009-01       Impact factor: 3.405

Review 3.  Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies.

Authors:  Joseph Lau; Hwan Lee; Julie Rousseau; François Bénard; Kuo-Shyan Lin
Journal:  Molecules       Date:  2022-08-04       Impact factor: 4.927

4.  Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.

Authors:  Marleen Melis; Magda Bijster; Monique de Visser; Mark W Konijnenberg; Jan de Swart; Edgar J Rolleman; Otto C Boerman; Eric P Krenning; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.